Idiopathic generalized epilepsy: genes and variants
Idiopathic generalized epilepsy is linked to 5 analyzed proteins (GABRA1, CASR, KCNMA1, SLC2A1 and ABCB1). 21 DNA variants are known to cause it; 160 more are uncertain, and 3 of those already look disease-causing on computable evidence.
Last updated 2026-09-30. Research information, not medical advice.
Genes linked to Idiopathic generalized epilepsy
GABRA1: Gamma-aminobutyric acid receptor subunit alpha-1
The gene product supplies the alpha-1 subunit of a pentameric GABA-A receptor, a ligand-gated chloride channel in the brain. GABA binding allows chloride influx that dampens neuronal activity, making this receptor important for inhibition and seizure biology.
20 disease-causing and 159 uncertain variants in GABRA1 are linked to Idiopathic generalized epilepsy.
CASR: Extracellular calcium-sensing receptor
It senses extracellular calcium in the parathyroid gland and kidney and adjusts parathyroid-hormone secretion and renal calcium handling accordingly. Loss-of-function variants cause familial hypocalciuric hypercalcemia or neonatal severe hyperparathyroidism, whereas activating variants cause autosomal dominant hypocalcemia.
0 disease-causing and 1 uncertain variants in CASR are linked to Idiopathic generalized epilepsy.
KCNMA1: Calcium-activated potassium channel subunit alpha-1
Its large-conductance potassium current couples membrane voltage and intracellular calcium to rapid repolarization in neurons, smooth muscle, and other excitable cells. Gain- and loss-of-function variants can cause paroxysmal dyskinesia, epilepsy, developmental impairment, and movement disorders.
0 disease-causing and 0 uncertain variants in KCNMA1 are linked to Idiopathic generalized epilepsy.
SLC2A1: Solute carrier family 2, facilitated glucose transporter member 1
It provides basal glucose uptake in many tissues and is the principal route for glucose entry across the blood-brain barrier. Haploinsufficiency causes GLUT1 deficiency syndrome with epilepsy, developmental impairment, and movement disorders from inadequate brain glucose delivery.
0 disease-causing and 0 uncertain variants in SLC2A1 are linked to Idiopathic generalized epilepsy.
ABCB1: ATP-dependent translocase ABCB1
It uses ATP to export a broad range of drugs and xenobiotics across intestinal, hepatic, renal, blood-brain-barrier, and other membranes. Its activity strongly influences drug absorption and tissue exposure and can contribute to multidrug resistance in cancer.
1 disease-causing and 0 uncertain variants in ABCB1 are linked to Idiopathic generalized epilepsy.
Where Idiopathic generalized epilepsy variants cluster
- GABRA1 Transmembrane (positions 280–301): 5 of 20 disease-causing changes, 5.2× more than its size predicts.
Known disease-causing variants in Idiopathic generalized epilepsy
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| GABRA1 R214C | 214 | Extracellular | Disease-causing (★★) |
| GABRA1 R214H | 214 | Extracellular | Disease-causing (★★) |
| GABRA1 T289A | 289 | Transmembrane | Disease-causing (★★) |
| GABRA1 R147Q | 147 | Extracellular | Disease-causing (★★) |
| GABRA1 T295I | 295 | Transmembrane | Disease-causing (★★) |
| GABRA1 T292I | 292 | Transmembrane | Disease-causing (★) |
| GABRA1 S213T | 213 | Extracellular | Disease-causing (★) |
| GABRA1 E277G | 277 | Cytoplasmic | Disease-causing (★) |
| GABRA1 F42L | 42 | Extracellular | Disease-causing (★) |
| GABRA1 F92S | 92 | Extracellular | Disease-causing (★) |
| GABRA1 G251S | 251 | Extracellular | Disease-causing (★) |
| GABRA1 Y252C | 252 | Extracellular | Disease-causing (★) |
| GABRA1 M263T | 263 | Transmembrane | Disease-causing (★) |
| GABRA1 L267F | 267 | Transmembrane | Disease-causing (★) |
| GABRA1 N275K | 275 | Cytoplasmic | Disease-causing (★) |
| GABRA1 T288I | 288 | Transmembrane | Disease-causing (★) |
| GABRA1 F325L | 325 | Transmembrane | Disease-causing (★) |
| GABRA1 A188D | 188 | Extracellular | Disease-causing (★) |
| GABRA1 P280Q | 280 | Transmembrane | Disease-causing (★) |
| GABRA1 R2K | 2 | Disease-causing (★) | |
| ABCB1 S893Y | 893 | ABC transmembrane type-1 2 | Disease-causing |
Uncertain variants in Idiopathic generalized epilepsy that look disease-causing
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| GABRA1 R214S | 214 | Extracellular | Conflicting reports (★) | +6: 3 other pathogenic changes within 3 positions; R214H at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.89 |
| GABRA1 N275S | 275 | Cytoplasmic | Uncertain (★★) | +6: 2 other pathogenic changes within 3 positions; N275K at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.65 |
| GABRA1 E277D | 277 | Cytoplasmic | Uncertain (★) | +6: 3 other pathogenic changes within 3 positions; E277G at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.95 |
Which prediction tools work for Idiopathic generalized epilepsy
How often each tool ranks a disease-causing variant above a harmless one (AUROC × 100).
- PolyPhen-2: 91 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CATVariant: 87 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 83 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 79 out of 100
- SIFT: 72 out of 100
Diseases related to Idiopathic generalized epilepsy
- Epilepsy, idiopathic generalized, susceptibility to, 13, also linked to CASR, GABRA1, KCNMA1 and SLC2A1
- Hypertrophic cardiomyopathy, also linked to CASR
- Familial hypocalciuric hypercalcemia, also linked to CASR
- EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 2, also linked to GABRA1
- Autosomal dominant hypocalcemia, also linked to CASR
- GLUT1 deficiency syndrome, also linked to SLC2A1
- Encephalopathy due to GLUT1 deficiency, also linked to SLC2A1
- Childhood onset GLUT1 deficiency syndrome 2, also linked to SLC2A1
- Epilepsy, also linked to GABRA1
- Nephrolithiasis/nephrocalcinosis, also linked to CASR
- Neonatal severe primary hyperparathyroidism, also linked to CASR
- Generalized epilepsy-paroxysmal dyskinesia syndrome, also linked to KCNMA1
Frequently asked questions
Which genes are linked to Idiopathic generalized epilepsy?
In CATVariant, Idiopathic generalized epilepsy is linked to 5 analyzed proteins: GABRA1 (Gamma-aminobutyric acid receptor subunit alpha-1), CASR (Extracellular calcium-sensing receptor), KCNMA1 (Calcium-activated potassium channel subunit alpha-1), SLC2A1 (Solute carrier family 2, facilitated glucose transporter member 1) and ABCB1 (ATP-dependent translocase ABCB1).
How many genetic variants are linked to Idiopathic generalized epilepsy?
194 variants: 21 are classified as disease-causing (pathogenic or likely pathogenic) in ClinVar and 160 are of uncertain significance or have conflicting reports.
Which uncertain variants in Idiopathic generalized epilepsy look disease-causing?
3 uncertain variants reach the likely-pathogenic range of the ACMG/AMP points scale on computable evidence, for example GABRA1 R214S, GABRA1 N275S and GABRA1 E277D. These are leads for expert review, not diagnoses.
Which variant effect predictor works best for Idiopathic generalized epilepsy?
Among tools not trained on clinical labels, AlphaMissense separates this disease's known disease-causing variants from harmless ones best (AUROC 0.79, based on 16 disease-causing and 9 harmless variants).
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from the latest public CATVariant analysis of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center